Travere Therapeutics Q3'26 Earnings Preview
Travere Therapeutics is scheduled to report Q3'26 results on October 22. The report time is not specified.
Travere Therapeutics, Inc. (TVTX) is scheduled to report Q3'26 results on October 22; the announcement time has not been specified. The results are expected at 8:00 AM ET (12:00 PM UTC). For Q3'26, revenue is estimated at 195.68 million USD, while EPS (earnings per share) is forecast at 0.03 USD.